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Abstract 
Ephedrine biotransformation reactions were performed using strain Cun-
ninghamella elegans in order to obtain products similar to human metabolism 
products. The choice of strains used was based on previous literature review 
which identified the species Cunninghamella elegans as promising due to 
their phenotypic characteristics, such as expressing Oxidoreductases enzymes 
that are necessary for carrying out the oxidation and reduction reactions in 
the side chain of the molecule ephedrine, in addition to expressing mo-
nooxygenases enzymes cytochrome P450 superfamily, which in humans 
were found in the lipid bilayer of hepatocytes and were responsible for the 
hydroxylation process of substances. Therefore, it was performed experi-
ments with strains of Cunninghamella elegans acquired by the mycology 
collection of the Federal University of Pernambuco, originating from dif-
ferent ecosystems. From screening step, it selected URM 4428 strain to 
present better profile biocatalytic to ephedrine. The results demonstrate the 
gradual formation of bioproducts in reversible character, and the reduction 
of bioproducts accompanied by the recovery of the substrate. To our      
knowledge, there are not previous scientific literature focusing the bio-
transformation of ephedrine by fungi, which demonstrates the uniqueness 
specific to our research and presents C. elegans, as a promising auxiliary 
tool in the exploration and understanding of the metabolism of ampheta-
mine-type drugs in humans. 
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1. Introduction 
The approach called biotransformation or biocatalysis has been employed with 
varying purposes that include from the classical asymmetric producing biologi-
cally active substances or their intermediates, resolution of racemic mixtures, 
degradation of environmental pollutants, biosorption of heavy metals and bio-
surfactant production. As well as the aforsaid, the use of microbial models in bi-
otransformation studies is also used to mimic human metabolism. The ability of 
microorganisms (MO), especially fungi, to mimic human metabolism has re-
ceived much attention in recent decades. The use of microbial models for the 
study and obtaining products of human metabolism has been shown to be a very 
promising tool [1]-[6].  
Increasingly, the use of these models has proved a complementary tool in the 
study of the pharmacokinetics of many drugs, emerging as a reliable and effi-
cient alternative to rationalize studies involving experimental animals or even as 
an alternative to synthetic chemical in obtaining considerable amounts of a se-
ries of derivatives of drugs and medicines. However, biotransformation reactions 
and/or biocatalysis with the use of whole microorganism that advantages [7] in-
clude simplicity, low cost and facility of manipulation, possibility of screening 
for a large number of drugs and strains, reproducibility, possibility of working 
on a large scale, allowing isolation and structural identification, enzymatic ma-
chinery viable and recyclable. As well as this, it allows for coenzyme and cofac-
tors high regio-, chemo- and enantio-selectivity, as well as making the work un-
der mild and ecological conditions more acceptable when compared with clas-
sical chemical techniques. 
Among the available microbial models, filamentous fungi can be considered 
the most promising, besides providing a reasonable amount of biomass (bioca-
talyst) in a relatively short time. They are eukaryotic and therefore, closer to the 
human system of mammals than bacteria [8]. 
The species Cunninghamella elegans Lendner 1907 is the most important 
among Zygomycetes distributed worldwide and widely used in science. The se-
paration of the species occurs, among other criteria—the optimal temperature 
for the growth of culture. The Cunninghamella are sensitive to variations related 
to the constitution of the medium, temperature and humidity, which can result 
in differences in growing isolates of the same origin. However, the biotechno-
logical potential of C. elegans can be considered for their presence in studies that 
relate to the metabolism of recalcitrant compounds, biological models for meta-
bolizing drugs by fungi, DNA extraction in large scale, and microbiological 
production processes chitin and chitosan [9] [10] [11] [12]. 
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The choice of strains used was based on previous literature review, which 
identified the species C. elegans as promising due to their phenotypic characte-
ristics, such as expressing oxidoreductases enzymes that are necessary for carry-
ing out the oxidation and reduction reactions in the side chain of the ephedrine 
molecule. There are also present in this organism monooxygenases enzymes for 
cytochrome P450 superfamily, which in humans are found in the lipid bilayer of 
hepatocytes and are responsible for the hydroxylation process of substances. 
This study aimed to perform biotransformation reactions using integrity cells 
cultures of microorganisms as a catalyst and supplemented with ephedrine as 
exogenous substrate. Furthermore, we obtained biotransformation products 
from the use of C. elegans and optimization of biocatalysis systems and devel-
oping the biotransformation reactions. 
2. Material and Methods 
2.1. Collection and Growth Optimization of Microorganisms 
Strains Cunninghamella elegans (URM 2450, URM 1591, URM 2136, URM 
2497, URM 2084, URM 4428, UM 3172, URM 4271, URM 6175, URM 5017, 
URM 3173, URM 4473, URM 4017, URM 4177, URM 5656, URM 5780, URM 
6017) belonging to University Recife Mycology of the Federal University of Per-
nambuco in the form of culture tubes containing potato dextrose agar. 
Afterwards, spore cultures were removed with handles inoculation on laminar 
flow hood and placed in cryovials, containing 1 mL TSB-broth Glycerol 10% and 
stored at −20˚C for the maintenance of enzymatic ability of microorganisms. In 
order to optimization and growth of microorganisms and acquisition of appro-
priate biomass for biotransformation reactions, the cryovials containing spores 
were thawed slowly and subcultured into tubes containing Agar Sabouraud Hi-
media (Composition: Dextrose 40.000 g/L, mycological, peptone 10.000 g/L and 
agar 15.000 g/L) and incubated for 4 days at 28˚C.  
2.2. Determination of Reaction Conditions 
For the acquire biomass were tested malt, Sabouraud and potato sucrose broth at 
temperatures of 28˚C and 36˚C and pH 5.0, 6.0 and 7.0, during three days in ro-
tary shaker (shaker) at 140 rpm. There were no significant differences in the 
formation of biomass between different broths at temperatures of 28˚C and pH 
6.0 approximately, and thus, suitable conditions for the acquisition of biomass 
chosen for the reactions. Considering that income equality between the three 
types of broths, it was defined using the broth potato sucrose by economic effi-
ciency issues and operational research, being the most cost-effective and aimed 
at future production on a larger scale. 
2.3. Growth and Optimization of Microorganisms to  
Perform Screening 
For determine what time should be made to supplement ephedrine in reaction 
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broths, aimed at realization of biocatalysis reactions, it is to performed curve for 
the elucidation of the microorganism growth phases. The method used was the 
optical density. By this method, a light beam crosses a cell suspension and re-
ducing the amount of transmitted light, resulting from diffraction, it is consi-
dered a measure of cell density [13].  
The growth of C. elegans URM 4428 was performed in microplate with refer-
ence to the method recommended by CLSI [14]. First, the fungus was grown at 
28˚C in tubes containing Sabouraud dextrose agar for 72 h. Then, cell suspen-
sions were prepared in RPMI medium (L-glutamine without sodium bicarbo-
nate) containing 0.4 × 104 to 5 × 104 CFU/mL. The suspension containing the 
microorganisms was placed in the microplate in sextuplicates, followed by first 
reading spectrophotometer, which was considered as zero time; also added to 
the microplate only RPMI medium without the presence of microorganisms in 
order to demonstrate that the increase in absorbance readings of suspensions 
would be associated with the growth of microorganisms. Immediately after the 
first reading, the microplate with the suspensions and broths was placed in an 
oven at 28˚C. In the time zero tests were performed on days 3, 6, 9, 12, 24, 36, 
48, 60 and 72 hat wavelengths 570 nm and 690 nm in Spectra Max M2 spectro-
photometer. 
2.4. Determination of Standard Curve Ephedrine 
For determine the ephedrine concentrations to be used as a substrate in the bio-
transformation reactions by the enzymes present in microorganisms, calibration 
curves were done at concentrations of 600, 800, 1000, 1200, 1400 and 1600 
µg/mL, thus obtaining the linearity (R2 = 0.9979). For the substrate preparation 
used 0.8 g of ephedrine in 50 mL of distilled water in a volumetric flask (C = 1.6 
µg/mL). The biotransformation reactions were performed after the filtering of 
the means containing microorganisms. Furthermore, it was added 3 g biomass 
phosphate buffer solution with pH 5.0, 6.0 and 7.0, respectively, performed at 
temperatures of 28˚C and 36˚C. These reactions were supplemented with 
aqueous ephedrine work solutions 0.16%. The resulting broth filtrate was also 
supplemented with 0.16% ephedrine. 
Reactions were carried out with the same microorganisms that have not un-
dergone filtering or whole broth containing the microorganisms and supple-
mented with aqueous ephedrine work solution. The best result was one where 
there was no separation between microorganism and broth. The experiments 
were performed at 28˚C temperature and 36˚C and pH 5.0, 6.0 and 7.0. Thus, it 
was considered that these are the right conditions, and it was decided to use the 
temperature of 36˚C. Such a choice happened given that temperature approach-
ing the human physiological temperature. 
2.5. Monitoring of Biotransformation Reactions 
For the monitoring of biotransformation reactions it was conducted screening 
tests lasting 10 days, counting the first 24 h after the day that supplementation 
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was performed. For the screening steps every 24 h, aliquots were removed 7 mL, 
raised to pH 10, with NaOH 0.01 M (for the extraction of ephedrine free base), 
added 3 mL of ethyl acetate. The tubes were slowly stirred to avoid the formation 
of emulsion, centrifuged at 4000 rpm for 30 min for complete separation of the 
organic and aqueous phases. 2 mL of the organic phase were removed with the 
aid of micropipette, placed in vials and taken to a water bath at 70˚C to make the 
concentration. After being concentrated, products were reconstituted with 200 
µL of methanol to follow the reactions using analysis by Thin Layer Chromato-
graphy (TLC), phase Gas Chromatography with Ionization Flame Detector (GC/ 
FID) and confirmation of Gas Chromatography Mass Detector (GC/MS), fol-
lowing methods previously reported and validated by our research group [15] 
[16] [17].  
2.6. Chromatographic Analysis 
The effectiveness of biocatalytic reactions was determined by the application and 
analysis by two chromatographic methods: The Thin Layer Chromatography 
(TLC) in the screening step and Gas Chromatography (GC) and (CG-MS) to 
confirmation. The monitoring performed TLC using aluminum plates chroma-
tographic Alugram® Xtra SIL G/UV 254 in the size of 20 cm × 20 cm and a 
thickness of 0.20 mm, employing silica gel 60GF as stationary phase. The mobile 
phase used was methanol: ammonia (100:0.5). The migration distance was 10 
cm. For detection, plates were dried in an oven at a temperature of 100˚C for 10 
min and visualized under UV light with 254 nm. As chromogenic reagents it was 
used Nihidrina and Dragendorf. The monitoring of biotransformation reactions 
was performed by GC/FID coupled with flame ionization detector(CG 2010 
Shimadzu) for the qualitative analysis and confirmation in the chromatograph to 
gas CG 5975C coupled to a detector 7890A mass (Agilent Technologies, CA, 
USA), from Toxicology Laboratory of the Faculty of Pharmacy at UFRGS 
(LABTOXICO) [17]. In the analysis by GC/FID was used as the nitrogen carrier 
gas with a flow rate of 1.0 ml/min and synthetic air and hydrogen as auxiliary 
gas to the flame. The injector was maintained at a temperature of 220˚C and op-
erated in 1:50 split mode. The chromatographic analyzes were performed on a 
Durabond-DB5 column (30 × 0.25 mm × 0.25 µ). The oven temperature was 
programmed starting at 80˚C (3 min) with a ramp of 50˚C/min to 280˚C (3 min) 
resulting in 10 min as total time of analysis. 
In the analysis by GC/MS was used as carrier gas helium ultrapure with a flow 
rate of 1.0 ml/min. The injector was maintained at a temperature of 220˚C and 
operated in 1:50 split mode. The chromatographic analyzes were performed on 
an Agilent-DB5-MS column (30 × 0.25 mm × 0.25 µ). The temperatures of the 
interface, the ion source and the quadrupole were maintained at 280˚C, 230˚C 
and 150˚C, respectively. The column temperatures were the same as used in 
GC/FID. The mass detector was operated at 70 ev electron impact system and 
analyzes were performed in SCAN mode range from 50 to 450 m/z. The total 
analysis time was 10 min.  
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3. Results and Discussion 
The biotransformations reactions of ephedrine mediated by C. elegans followed 
the flowchart shown in Figure 1.  
The choice of strains used was based on previous literature review which 
identified the species C. elegans as promising due to their phenotypic characte-
ristics, such as expressing oxidoreductases enzymes that were necessary for carry-
ing out the oxidation and reduction reactions in the side chain of the ephedrine 
molecule. Also present in this organism is the monooxygenases enzyme cytoch-
rome P450 superfamily, which in humans is found in the lipid bilayer of hepato-
cytes and is responsible for the hydroxylation process of substances [6] [18].  
For optimizing the growth of microorganisms, strains were tested on different 
culture media, temperature and pH (Table 1). The extraction of ephedrine and 
products was performed by raising the pH from 6.0 to 10, all the aliquots with 
0.01 mole sodium hydroxide and fixed with 0.1 molar hydrochloric acid as 
needed. The optimum conditions for growth of microorganisms were pH 6.0 for 
potato sucrose broth and temperature of 28˚C rotating incubator for three days 
(Table 1). 
 
 
Figure 1. Flowchart of the experiment phases. 
 
Table 1. Growth and optimization of microorganisms to perform screnning. 
Microorganism 
Incubation conditions 
Biomass (g) Culture  
medium 
Temperature 
(˚C) 
Time 
(days) 
Cunninghamella elegans URM 1591 PSB 26-28 3 ±20 
Cunninghamella elegans URM 5780 PSB 26-28 3 ±20 
Cunninghamella elegans URM 4271 PSB 26-28 3 ±20 
Cunninghamella elegans URM 4428 PSB 26-28 3 ±20 
PSB = Potato sucrose broth. 
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On the conditions tested, the strain of C. elegans 4428 demonstrated most 
promising biocatalytic potential and was selected for the development of this 
work. To determine what time should be made to supplement ephedrine in reac-
tion broths, aiming at realization of biocatalysis reactions, was performed and 
growth curve for the determination of the microorganism growth phases. The 
method employed was the optical density and the results are the optimum point 
to supplement the broths shown in Table 2. 
According to Figure 2, the latency phase, or lag phase, during which the mi-
croorganism adapts to the new physical-chemical conditions of the environment 
in order to grow, occurs in the first 12 h of onset of growth in both growth me- 
 
 
Figure 2. Growth curve of Cunninghamella elegans 4428 strains in RPMI medium (with 
and without microorganism). The latency phase, or lag phase, occurs between 0 and 12 
hours, from 12 hours to 48 hours, the growth phase occurs and the stationary phase oc-
curs after 48 hours. 
 
Table 2. Time versus absorbance Cunninghamella elegans (RPMI). 
Time/h RPMI (with microorganism) RPMI (without microorganism) 
0 0.045  
3 0.045 0.045 
6 0.045 0.044 
9 0.045 0.045 
12 0.045 0.045 
24 0.060 0.045 
36 0.072 0.045 
48 0.084 0.045 
60 0.084 0.045 
72 0.083 0.046 
84 0.084 0.045 
RPMI = Roswell Park Memorial Institute (RPMI) 1640 medium. 
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dia, and is followed by the growth stage progressive period which the growth is 
accelerated and metabolic activity is high. This cell population is perceptibly in-
creased in accordance with the time chart, and occurs between 12 and 48 h. It is 
followed by the deceleration phase and stationary phase, in which there is deple-
tion of substrates. At this stage, the cells cease their growth, given that the max-
imum capacity reached in their development [13]. From a screening step, in this 
research, experiments were conducted in optimal conditions for growth, acquisi-
tion of biomass and biocatalysis reaction. Opted for the use of microorganism 
growth 72 h to effect the supplementation with ephedrine work solution, since in 
this phase, there is greater enzyme stability, thus avoiding the transient forma-
tion of products. 
Fixed the ideal conditions of the experiment, the process was developed with 
the cultivation of microorganisms of the cells in an oven for four days, and sub-
sequent process of acquiring biomass and studies of growth phases. Verifica- 
tion of the stability of all the elements present in the biotransformation reaction 
process that has relevance to discard the possibility of abiotic degradation of the 
substrate and exudation of the assembly of these components. To the end, expe-
riments were conducted in which we evaluated the product formation in the 
presence and absence of biocatalytic agent (fungi), as well as the presence or ab-
sence of substrate. The groups evaluated in this study step were described below. 
1) white Medium (MB): bottle containing only broth without microorganism 
and without substrate (reaction to check exudation products broth); 2) Total 
White Medium (MTBR): vial containing broth, microorganism, but without the 
substrate (reactions for checking exudation products MO); 3) Part ephedrine 
(Mef): 25 mL of the aqueous solution of ephedrine 1600 μg/mL was added to the 
medium containing broth but no microorganism (reaction substrate for the sta-
bility check); 4) Total Medium (TM): vial for performing the complete reaction 
that contains all elements for biotransformation, or broth, microorganism and 
25 mL of sat. aqueous ephedrine 1600 µg/mL (MT). After supplementation, the 
flasks were placed back on the rotary shaker and the temperature was raised to 
36˚C, the speed of 140 rpm. 7 mL aliquots were taken which were raised to pH 
10 with NaOH 0.01 M and adding 3 mL of ethyl acetate, stirred slowly bottles 
were centrifuged at 4000 rpm for 30 min to complete separation of the organic 
phase and aqueous phase. 2 mL of organic phase was removed and placed in 
vials and taken to a water bath at 70˚C to make the concentration. After being 
concentrated, products were reconstituted with 200 µL of methanol. 
Ephedrine showed good resolution and its chromatographic retention time 
was 6.16 min in GC/MS (Figure 3) and 7.08 min in GC/FID. 
Various biotransformation products were obtained as verified by analysis on 
GC/FID (Figure 4) and confirmed by GC/MS. Among the products obtained, 
three were selected (P1, P2 and P3) (Figure 5). Products 4, 5 and 6 are shown in 
Figure 6. 
Through the data obtained, the formation of products was observed to follow 
a same pattern behavior bioproducts from the obtained; three showed higher  
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Figure 3. GC/MS chromatogram of ephedrine. 
 
 
Figure 4. GC/FID chromatogram of the Ephedrine reaction with microorganisms at 48 hours. 
 
yield and were then selected for monitoring of the biocatalytic reactions, and the 
points in 2 days, 5 days and 9 days, as shown in Figure 7. During the first two 
days of biocatalysis reactions, it was observed the constant increase of the bio-
transformation products P1, P2 and P3, and decreased concentration of ephe-
drine. This behavior was repeated in the fifth and ninth days for the three prod-
ucts, the product 2 (P2), the only detected on the seventh day. It was observed 
that after having increased the reduction products thereof, with a proportional 
recovery of the substrate, which suggested that the reaction had reversible cha-
racters. 
For better understanding of the reactions, aspects regarding the degradation 
resulting from extractive processes, transformations, stability problems and  
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Figure 5. GC/MS chromatogram of ephedrine (48 h of reaction) and its biotransformation products’ mass spectrum. 
 
 
Figure 6. GC/MS chromatogram of ephedrine (48 h of reaction) and its biotransformation products’ mass spectrum. 
 
possible presence of contamination of products, were conducted in several expe-
riments, named control experiments, which were switched to the presence of the 
substrate, the biocatalytic agent and the culture medium alone and in combina-
tion. The results of these tests carefully evaluated, did not afford the detection 
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Figure 7. Kinetic of 10 days of Ephedrine biotransformation reaction with Cunningha-
mella elegans URM 4428. 
 
of substances obtained as the product of the biotransformation reactions, thus 
confirming the biotransform products obtained during the reactions were me-
diated by C. elegans biocatalysis. 
The study of ephedrine biotransformation kinetics in hours for the experi-
ment conducted for 72 h, confirms the default behavior of a reversible reaction 
when it has been observed over a period of 10 days. In fact, it is a reversible reac-
tion in which the maximum formation of products P2, P3 and P1 occurs in 12 h 
and 15 h respectively. All products have reached their lowest point in 24, 54 and 
72 h, in which proportional increase of the concentration of ephedrine (sub-
strate) is observed. 
To confirm the reversible character reactions, more detailed tests were con-
ducted. To the reaction, kinetics studies were conducted for 3 days of experi-
ments (72 h) for removal of aliquots in triplicates every 3 h by repeating the 
same procedures used when the extraction range and concentration of the ali-
quots were 24 h for 10 days. The results are shown in Figure 8. 
A careful review of scientific literature to date, has not found references to the 
biotransformation of ephedrine yeast, especially C. elegans, which demonstrates 
the uniqueness specific to our research. The data in the literature regarding the 
biotransformation ephedrine and other amphetamines in different animal spe-
cies is incipient, limiting the understanding of the pharmacological activity and 
potential toxicity of this class of substances. Neither was it highlighted in the 
various ephedrine biotransformation studies in rats and mice i.e. the species 
most commonly used in toxicological studies. 
The existing differences in metabolism between species must be taken into 
consideration and it is noteworthy that some biotransformation products can 
provide equivalent toxicity or greater to the drug administered and should be 
evaluated in isolation. Small animals such as mice, biotransforms compounds 
generally at a faster rate than that observed when the experiment occurs in larger 
animals such as humans. This is in line with differences in overall metabolic rate. 
As Timbrell (2004), there are qualitative and quantitative differences between 
species with regard to the biotransformation of amphetamine (Figure 9). Similar  
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Figure 8. Kinetic of 72 hours of Ephedrine biotransformation reaction with Cunningha-
mella elegans URM 4428. 
 
 
Figure 9. Differences between species with regard to the biotransformation of ampheta-
min. 
 
results were not found for ephedrine, but we suggested that one should be care-
ful in extrapolating results obtained in tests on laboratory animals to assess the 
risk of use by humans. 
Several factors may affect the biotransformation of drugs. These factors may 
be chemical and/or biological, also considering toxic effects. Chemical factors 
that need to be taken into consideration are the lipophilicity, size, structure, pK, 
ionization and chirality of the molecule. Already biological factors present in re-
lation to the species, breed, sex, genetic factors, disease and pathology [19]. 
Also under consideration were not only the large variations in susceptibility 
between species, but also the various factors that may be involved in any given 
species. In this sense, there is the genetic constitution of specific body as a relevant 
factor involved in metabolizing substances. Code can be added to the importance 
of other internal factors, such as age and certain features of their body systems. 
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Among the external factors, dose and used associations can influence the bio-
transformation; the way is the diet management and exposure to other foreign 
compounds, which can result in deviations of biotransformation patterns and 
hence the detectability in biological samples and toxicity profiles. 
According Timbrell (2004), amphetamine is biotransformed in rabits for 
phenylacetone (Figure 9). This mechanism probably involves the oxidation of 
the carbon atom, to obtain a carbinolamine, which can rearrange to the ketone 
with loss of ammonia. Alternatively, it is possible that the reaction has continued 
through phenylacetoneneoxome, isolated as a product, which has several possi-
ble routes to their training. Ranging from the hydrolyzed to phenylacetone. Also 
N-hydroxylation amphetamine is liable to occur and may lead to phenylacetone 
as a product of biotransformation. This example illustrates the possibility of a 
varied number of alternative routes for obtaining amphetamines biotransforma-
tion products; many of them have not yet described in the literature. 
In this context, the use of microorganism demonstrates to be an important 
promising tool for better understanding of biotransformation processes of this 
class of substances and has the advantage of optimizing the rationalization and 
the use of experimental animals such as rats, rabbits and guinea pigs, showing 
higher ethical commitment and avoiding lengthy deliberative processes by the 
ethics committees of the entities where these experiments are performed. It also 
highlights the fact that the microorganisms, mostly achieve rapid growth and 
development of their phenotypic expressions, which provides the speed of ob-
taining products by biotransformation large-scale process (Figure 10). 
The biotransformation reactions mediated Cunninghamelas shown to be a 
promising tool in the study of ephedrine biotransformation and other amphe-
tamine derivatives, and demonstrated the applicability of the biotransformation  
 
 
Figure 10. Cytochrome P450 metabolism in microorganisms and humans. 
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to study metabolism in humans. In the reactions obtained in this study, it was 
found the presence of several biotransformation products through the optimal 
conditions established in the experiment, in reversible character. The reproduci-
bility of the product was confirmed by repeating the experiments, always ac-
companied by other reactions without microorganisms and without substrate, to 
ensure biocatalysis. From the mass spectra biocatalytic, one profile was obtained 
with formation of six majority products for 48 h, and this reaction had reversi-
bility, observing the recovery of the substrate in time of lowering products. To 
complete elucidation of the structure of the products obtained in future, work 
steps are conducted on a larger scale experiment; isolation of products are eva-
luated by Nuclear Magnetic Ressonance (NMR); Infra-red and High-resolution 
Magnetic Ressonance (HRMNS) is performing parallel tests between MO and 
animal tests and clinical trials. 
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